Association between skeletal fractures and sleep medication in patients with chronic kidney disease
Chikao Onogi1, Yu Watanabe2, Akihito Tanaka3
1Department of Nephrology, Graduate School of Medicine, Nagoya University, Nagoya, Japan. onogi.chikao.d7@a.mail.nagoya-u.ac.jp.
No abstract available in PubMed .
More Related Videos
07:04A High-performance Liquid Chromatography Measurement of Kynurenine and Kynurenic Acid: Relating Biochemistry to Cognition and Sleep in Rats
Published on: August 19, 2018
04:33Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
Published on: April 26, 2024
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Chronic Kidney Disease III: Interprofessional Care
REM Sleep Behavior Disorder
RBD is significantly associated with...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
